FDA approves treatment for two rare types of non-Hodgkin lymphoma - FDA Press Releases

FDA approves new drug for the treatment of adults with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy

from Food and Drug Administration--Press Releases https://ift.tt/2njWlz0
via IFTTT